平行双D技术腔内修复远端囊状腹主动脉瘤与髂总动脉瘤的治疗结果
单中心回顾性分析2007年4月至2019年4月910例EVAR中21例(2%)采用双D技术(DDT-EVAR)的远端囊状腹主动脉瘤、髂动脉瘤及慢性B型主动脉夹层病例。手术成功率100%,计划保留的肠系膜下动脉12例全部成功,无I型及III型内漏,中位随访18个月仅2例因支架腿闭塞需再干预。
要点
- DDT-EVAR适用于肾下动脉至主动脉分叉长度不足70 mm或分叉狭窄的远端腹主动脉瘤与髂动脉瘤。
- 该技术可保留肠系膜下动脉和髂内动脉,即使分叉型支架无法保留时亦可尝试。
- 本组手术成功率100%,无I型及III型内漏,2例支架腿闭塞需再干预。
核心结论
- DDT-EVAR是治疗远端腹主动脉瘤、髂总动脉瘤及慢性B型主动脉夹层的安全且直接的技术,可能有助于保留肠系膜下动脉和髂内动脉。
研究设计与样本
- 单中心回顾性研究,2007年4月至2019年4月共910例EVAR中21例(2%)行DDT-EVAR。
- 患者中位年龄74岁(范围52-85),男性19例(90%)。
- 6例腹主动脉瘤(均为囊状,1例破裂)、12例髂动脉瘤、3例慢性B型主动脉夹层行再入口封闭。
主要发现
- 手术成功率100%,中位手术时间146分钟(范围88-324)。
- 计划保留的肠系膜下动脉12例全部成功,未观察到I型和III型内漏。
- 慢性B型主动脉夹层假腔血流减少或消失,住院期间无手术相关并发症。
- 2例使用Endurant II支架腿者术后出现支架腿闭塞,需再干预。
- 中位随访18个月(范围4-50)内其他患者无需额外治疗。
关键数值与推荐
- 腹主动脉瘤直径45 mm(范围34-71),髂动脉瘤直径34 mm(范围25-58)。
- 19例(90%)使用主动脉袖套;Endurant II用于12例,Excluder用于7例。
- 支架腿中Endurant II用于20例,VBX用于1例。
临床怎么用
- 对肾下动脉至主动脉分叉长度不足70 mm或分叉狭窄、不适合分叉型支架的远端囊状腹主动脉瘤及髂动脉瘤,可考虑DDT-EVAR。
- 使用DDT-EVAR时可有意识地保留肠系膜下动脉和髂内动脉。
- 术后需关注支架腿闭塞风险,本组2例需再干预。
局限性
- 单中心回顾性研究,样本量仅21例。
- 中位随访时间仅18个月(范围4-50)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Endovascular aneurysm repair (EVAR) using a bifurcated stent graft may involve technical challenges when aortic disease (aneurysm or dissection) consists of a length <70 mm between the inferior renal artery and aortic bifurcation or narrow aortic bifurcation that is common in asymmetric distal abdominal aortic aneurysms (AAAs) or iliac artery aneurysms (IAAs). We use EVAR with the double D technique (DDT-EVAR) for such cases, which involves straight type of stent grafts with same diameter in left and right that are deployed parallel to an aortic cuff that has been previously placed. In addition, DDT-EVAR can preserve the inferior mesenteric artery (IMA) for IAA. METHODS: DDT-EVAR was performed for 21 of 910 (2%) cases from April 2007 to April 2019 at our institution. The median patient age was 74 years (range, 52-85). Nineteen patients (90%) were men. Six patients (all saccular; 1 rupture) had AAAs, 12 had IAAs, and 3 had chronic type B aortic dissociation (TBAD) for re-entry closure. AAA and IAA had diameters of 45 mm (range, 34-71) and 34 mm (range, 25-58), respectively. An aortic cuff was used for 19 (90%) cases. Endurant II (Medtronic, Santa Rosa, CA) was used for 12 cases. The Excluder (W.L. Gore & Associates, Inc, Flagstaff, AZ) was used for 7 cases. Endurant II was used for 20 cases, and the VBX (W.L. Gore & Associates, Inc) was used for 1 case as stent-graft limbs. RESULTS: The procedural success rate was 100%. The median operative time was 146 min (range, 88-324). IMA planned for preservation was successful for all 12 cases. Type I and type III endoleaks were not observed. With TBAD, flow to the false lumen decreased or disappeared, and no complications during the hospital stay were associated with the procedure. For 2 patients whose procedure involved Endurant II stent-graft limb, limb occlusions were observed postoperatively, and reintervention was required. No other patients required additional treatment at a median follow-up of 18 months (range, 4-50). CONCLUSIONS: DDT-EVAR is a safe and straightforward technique for the treatment of distal AAA, common iliac artery aneurysm, and TBAD. It may help preserve the IMA and internal iliac artery, even when it is impossible to preserve them with a bifurcated stent graft.
引用
- Mizoguchi T, Morikage N, Takeuchi Y, et al. Treatment Results of Endovascular Aneurysm Repair Using the Parallel Stent-Graft Double D Technique for Distal Saccular Abdominal Aortic Aneurysms and Common Iliac Aneurysms. Ann Vasc Surg. 2020. PMID: 32827677. doi:10.1016/j.avsg.2020.07.048
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。